Clinical studies showed that urinary AGT can dynamically monitor the recovery of renal status after an AKI attack and may predict the progression of AKI-CKD and treatment response of patients with AKI (Chen C et al., 2016; Cui et al., 2018). This evidence concerns the gene AGT and chronic kidney disease.